Dr. Greenberg presented new preclinical data from Vivreon Biosciences' Alzheimer's disease therapeutic program at the 18th International Conference on Alzheimer's Drug Discovery in Jersey City, NJ.
Vivreon presented our exciting preclinical data for our VV2003 ulcerative colitis program at Digestive Diseases Week 2017 in Chicago, IL.
Vivreon Biosciences Presents Data at International Conference on Alzheimer's Drug Discovery
Vivreon Biosciences Achieves Milestones in SBIR Grant from the National Institute on Aging
Vivreon Biosciences Announces Hiring of Chief Scientific Officer
Vivreon Biosciences Awarded Grant from Alzheimer's Drug Discovery Foundation
Oral Immune Therapeutics